And, NIST is always looking for opportunities to create new SRMs to drive innovation in emerging markets, like the monoclonal antibody SRM for biopharmaceutical manufacturers
The Economist talks about why American tobacco stocks have outperformed tech in recent years and textbook example of "price-inelastic" buyers: Over the past decade, the # of US smokers has declined by 20m (and cigarettes sold is down by 1/3rd) So, cigarette firms have charged more to their most committed smokers (operating margins grown from 50% to 60%) In 2025, cigarette makers in the US will make operating profit of $22B While the industry goes away, only the most addicted smokers are left
Excerpted from a recent issue of Jack Adamos Insider Plus .
Many users compare brands based on which flavor lineup and nicotine level best match their preferences
OCS target the whole body, while ICS focuses on the airways
Cough For several weeks or months after you quit smoking, you may notice that your coughing persists or that it occurs more frequently